STOCK TITAN

Disc Medicine, Inc. - $IRON STOCK NEWS

Welcome to our dedicated page for Disc Medicine news (Ticker: $IRON), a resource for investors and traders seeking the latest updates and insights on Disc Medicine stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Disc Medicine's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Disc Medicine's position in the market.

Rhea-AI Summary
Disc Medicine, Inc. (NASDAQ:IRON) receives Fast Track Designation from FDA for MWTX-003 in the treatment of polycythemia vera (PV)
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
-
Rhea-AI Summary
Disc Medicine, Inc. (NASDAQ:IRON) will participate in fireside chats at four upcoming investor conferences.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.18%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.73%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.63%
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.6%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.05%
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.06%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.61%
Tags
Disc Medicine, Inc.

Nasdaq:IRON

IRON Rankings

IRON Stock Data

795.54M
13.49M
13.38%
84.99%
7.53%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
WATERTOWN

About IRON

disc medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis) in hematologic diseases. focused on the hepcidin pathway, the master regulator of iron metabolism, disc is advancing first-in-class therapies to transform the treatment of hematologic diseases.